Skip to main content
FOCIS 2025 Main banner
Final Program


Final Program

  1. Home

  • Wednesday, Jun 25th
    3:15pm - 3:30pm East Coast USA Time
    Engineering Relapse-Resistant CAR T-Cells for Blood Cancers (Penta T-Cells)
    Location: Salons H-K
    Presenting Author: Philipp C. Rommel, Dr. rer. nat. – University of Pennsylvania
    Immuno-engineering and Cellular Therapies
  • Wednesday, Jun 25th
    3:30pm - 3:45pm East Coast USA Time
    Gut Microbiota and Metabolites Influence CAR-T Cell Persistence, Efficacy and Predict Outcomes in Multiple Myeloma
    Location: Salons H-K
    Presenting Author: Manel Juan, MD, PhD – Hospital Clinic de Barcelona
    Immuno-engineering and Cellular Therapies
  • Thursday, Jun 26th
    4:25pm - 4:40pm East Coast USA Time
    Engineering Thymic Selection to Promote Acceptance of Allogeneic Transplantation
    Location: Salons F-G
    Presenting Author: Valentina Consoli – IRCCS Ospedale San Raffaele, San Raffaele Telethon Institute for Gene Therapy
    Immuno-engineering and Cellular Therapies
  • Thursday, Jun 26th
    5:10pm - 5:25pm East Coast USA Time
    Engineering of Regulatory T Cells with Hepatocyte-specific Chimeric Antigen Receptor Enhances Liver Tissue Trafficking
    Location: Salons F-G
    Presenting Author: Marc Martinez-Llordella, PhD – Quell Therapeutics
    Immuno-engineering and Cellular Therapies
  • Thursday, Jun 26th
    5:25pm - 5:40pm East Coast USA Time
    Enhancing Adoptive Immunotherapy: Targeting Epstein-Barr Virus with Highly Active, Durable and Immunosuppression-resistant Cytotoxic CD4+T Cells
    Location: Salons A-D
    Presenting Author: Prabesh Khatiwada – Columbia University
    Immuno-engineering and Cellular Therapies
  • Thursday, Jun 26th
    6:10pm - 6:25pm East Coast USA Time
    Chemokine-engineered CAR-T Cells for Autoimmunity: Multiplexed mRNA Technology for Improved Mode of Action and Safety
    Location: Salons F-G
    Presenting Author: Norman M. Drzeniek, MD, PhD – Charité – University Medicine Berlin, BIH Center for Regenerative Therapies
    Immuno-engineering and Cellular Therapies
  • Friday, Jun 27th
    2:25pm - 2:40pm East Coast USA Time
    Use of Engineered CAR-Treg Cells to Induce Immune Tolerance in Liver Transplantation – Insights from the LIBERATE Clinical Trial
    Location: Salons A-D
    Presenting Author: Marc Martinez-Llordella, PhD – Quell Therapeutics
    Immuno-engineering and Cellular Therapies